Skin test for oxaliplatin allergy risk
Treatments studied
Part of Immune system & allergy clinical trials.
This study tests whether a simple skin test can predict allergic reactions to the chemotherapy drug oxaliplatin. It aims to help doctors identify patients at higher risk and adjust treatment to make it safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to receive chemotherapy that includes oxaliplatin, or might start it for the first time.
- You have not had a severe allergic reaction to oxaliplatin or other platinum drugs before.
- You are in fairly good health (able to do daily activities) and expected to live at least 3 more months.
- If you are of childbearing age, you must have a negative pregnancy test and use birth control during the study.
- You have not taken certain immune-suppressing medications (like steroids, tocilizumab, or omalizumab) within specified time frames.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, AC591, to see if it can prevent the nerve damage and pain that often comes with oxaliplatin chemotherapy for colorectal cancer. If you are about to start this type of chemo after surgery, this study might help reduce side effects.
This Phase 1 trial tests a targeted treatment delivered to the lungs for colorectal cancer that has spread to the lungs. It aims to see if the approach is safe and can reach lung tumors, especially when there are multiple lung lesions.
This trial tests whether ketotifen can protect against nerve damage (called peripheral neuropathy) caused by oxaliplatin, a common chemotherapy used for stage III colon cancer. If it works, it may help reduce tingling, numbness, or burning pain in the hands and feet.
This study looks at ways to prevent numbness or nerve pain in the hands and feet that can happen from oxaliplatin treatment. It includes people with colon or rectal cancer who will be getting standard chemotherapy with capecitabine plus oxaliplatin.
This trial tests whether wearing special surgical gloves during oxaliplatin chemotherapy can help prevent nerve damage (numbness or tingling) in people with advanced colon cancer.
This study checks if a substance called HMGB1 in your blood is linked to nerve damage and liver side effects from the chemotherapy drug oxaliplatin. It is for people with a specific type of stomach or pancreas cancer that can be surgically removed.
Hear when a new Hypersensitivity Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.